Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
P
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
ATHEX:PAP
|
GR |
|
GoTo Gojek Tokopedia PT Tbk
IDX:GOTO
|
ID |
|
eBay Inc
NASDAQ:EBAY
|
US |
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
IT |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
eHealth Inc
NASDAQ:EHTH
|
US |
|
Origin Materials Inc
NASDAQ:ORGN
|
US |
|
Prospect Capital Corp
NASDAQ:PSEC
|
US |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
U
|
Uniqa Insurance Group AG
VSE:UQA
|
AT |
|
Jarir Marketing Company SJSC
SAU:4190
|
SA |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
N
|
Novartis AG
DUS:NOT
|
CH |
|
R
|
Reckitt Benckiser Group PLC
DUS:3RB
|
UK |
|
G
|
Globaltrans Investment PLC
MOEX:GLTR
|
CY |
|
Jiangxi Copper Co Ltd
SSE:600362
|
CN |
Wall St Price Targets
CAPR Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CAPR is 55.76 USD with a low forecast of 43.43 USD and a high forecast of 66.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAPR's stock price target?
Price Target
55.76
USD
According to Wall Street analysts, the average 1-year price target for
CAPR is 55.76 USD with a low forecast of 43.43 USD and a high forecast of 66.15 USD.